Leerink stills believes Athenahealth will sell in $135-$140 range

Leerink analyst David Larsen continues to believe that Athenahealth will sell and the reported partnership of Veritas Capital and Elliott Management makes strategic sense. Veritas has several HCIT companies within its existing portfolio and Elliot still retains a about 9% stake in Athenahealth, according to Bloomberg, he contends. While a deal may still take some time to complete, Larsen continues to believe Athenahealth will sell in the $135-$140 range. The analyst reiterates a Market Perform rating on the shares.
https://thefly.com/landingPageNews.php?id=2815291